Embryonic tissue was fixed for 45 to 60 minutes with 4% paraformaldehyde (PFA) in PBS. For BrdU pulse labeling, pregnant mice were injected as previously described.
25 Cryostat sections (10–12 μm) were processed for antibody labeling as previously described.
51 Primary antibodies used are: rat anti-β-galactosidase (1:750–1000, a gift from Tom Glaser, University of Michigan, Ann Arbor, MI), mouse anti-p27/Kip1 (1:100, BD-Transduction Laboratories, Lexington, KY), rabbit anti-Ki67 (1:1000; Vector Laboratories, Burlingame, CA), rabbit anti-phosphorylated histone H3 (1:1000; Upstate Biotechnology, Lake Placid, NY), mouse anti-PCNA (1:1000; DakoCytomation, Carpinteria, CA), rat anti-BrdU (1:200; Serotec, Raleigh, NC), rabbit anti-β-catenin (1:4000; Sigma-Aldrich, St. Louis, MO), rabbit anti-Hes1 (1:1000; from the laboratory of NLB), rabbit anti-Ngn2 (1:1000, a gift from Masato Nakafuku, Cincinnati Children’s Medical Center), goat anti-Brn3b (1:50; Santa Cruz Biotechnology, Santa Cruz, CA), rabbit anti-Otx2 (1:2500; Chemicon, Temecula, CA), rabbit anti-Olig2 (1:1000, a gift from Masato Nakafuku), rabbit anti-RXRγ (1:200; Santa Cruz Biotechnology), rabbit anti-Ptf1a (1:800, a gift from Helena Edlund, University of Umea, Sweden). Secondary antibodies were directly conjugated with Alexa Fluor 488, Alexa Fluor 568, or Alexa 594 (1:1000–2000, Invitrogen-Molecular Probes, Eugene, OR) or indirectly with biotin (horse; 1:200, Vector Laboratories or rodent; 1:200, Jackson ImmunoReseach, West Grove, PA) and streptavidin-conjugated Texas red (1:200, Jackson ImmunoResearch). Nuclei were counterstained with 4,6-dimidino-2-phenylindole (DAPI). PCNA labeling was performed after antigen retrieval by immersion of slides in hot citric acid buffer for 30 to 40 minutes after anti-β-galactosidase detection. Anti-BrdU labeling was performed after antigen retrieval in 0.2 M HCl/0.5% Triton X-100 for 1 hour. At least four β-catenin mutant and control embryos were analyzed for β-catenin and β-galactosidase expression.